Key statistics
As of last trade, Novocure Ltd (038:DUS) traded at 9.30, 12.29% above the 52 week low of 8.28 set on Feb 10, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.26 |
|---|---|
| High | 9.30 |
| Low | 9.26 |
| Bid | 9.23 |
| Offer | 9.52 |
| Previous close | 9.34 |
| Average volume | 150.29 |
|---|---|
| Shares outstanding | 111.98m |
| Free float | 100.99m |
| P/E (TTM) | -- |
| Market cap | 1.23bn USD |
| EPS (TTM) | -1.61 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 11:30 GMT.
More ▼
Press releases
- U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
- Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
- Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
- Novocure Appoints Company President Frank Leonard as Chief Executive Officer
- Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
More ▼
